By vgreene, 8 July, 2021 The 2020 French Cardio Oncology Working Group provides monitoring recommendations based on specific agents w in class 4
By vgreene, 8 July, 2021 Bcr Abl kinase inhibitors can cause accelerated atherosclerosis peripheral artery dz development acute coronary syndrome stroke HTN hyperglycemia hypercholesterolemia pericardial effusion pulmonary arterial HTN QTc prolongation and occasionally LVSD
